NIH-funded research R15 grant

How the nucleus affects breast cancer spread and emerin’s role

Official title: Mechanotransduction from the tumor microenvironment to the nuclear envelope protein emerin enables nuclear softening during cancer metastasis

Funded at Rowan University · NIH-11444492 · Data updated 2026-11-12

A researcher-led project at Rowan University is exploring how the cell nucleus and a protein called emerin influence the spread of breast cancer, especially the aggressive triple-negative type.

More Metastasis research and trials

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionRowan University
NIH-funded
Lab location1 site (Glassboro, United States)
Project startSeptember 23, 2026
Project endAugust 31, 2029
Funding year2026
Award (this year)$564,078
NIH project number1R15CA309616-01A1
Project IDNIH-11444492 on NIH RePORTER

Who could benefit from this research

Could help

Patients with breast cancer, especially those with triple-negative breast cancer or high metastatic risk, could benefit from advances related to this research.

Less likely to help

Patients with breast cancer that do not rely on nucleus mechanics or emerin pathways for metastasis may see limited direct benefit.

What this research studies

Researchers will study how mechanical signals inside cancer cells change the nucleus via emerin and how this affects the cancer's ability to invade and metastasize. The work focuses on triple-negative breast cancer, a particularly hard-to-treat form, by examining nuclear mechanics and their link to cancer progression. They will use laboratory models to test if altering emerin levels can make cancer cells stiffer and less able to squeeze through tissues. This could point to new angles for therapies that slow or stop metastasis.

Why it matters

Potential benefit: If successful, this research could identify new targets to limit metastasis in breast cancer, potentially improving survival for patients with aggressive disease.

How similar studies have gone: Prior work has linked nuclear mechanics to cancer cell invasion, with some studies suggesting targeting nuclear stiffness can affect metastasis.

Where this research is happening

  • Rowan University
    Glassboro, United States
    Active

Researchers

  • Principal investigator: Holaska, James Michael — Rowan University
  • Study coordinator: Holaska, James Michael

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.